Selective Neck Dissection and Survival in Pathologically Node-Positive Oral Squamous Cell Carcinoma

被引:13
作者
Shimura, Shunichi [1 ]
Ogi, Kazuhiro [1 ]
Miyazaki, Akihiro [1 ]
Shimizu, Shota [1 ]
Kaneko, Takeshi [1 ]
Sonoda, Tomoko [2 ]
Kobayashi, Junichi [1 ]
Igarashi, Tomohiro [1 ]
Miyakawa, Akira [1 ]
Hasegawa, Tadashi [3 ]
Hiratsuka, Hiroyoshi [1 ]
机构
[1] Sapporo Med Univ, Sch Med, Dept Oral Surg, Chuo Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan
[2] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Chuo Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan
[3] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Chuo Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan
来源
CANCERS | 2019年 / 11卷 / 02期
关键词
oral squamous cell carcinoma; selective neck dissection; survival; metastatic nodal parameters; pathologically positive nodes; EXTRACAPSULAR SPREAD; COMPREHENSIVE NECK; NEGATIVE NECK; CANCER; HEAD; METASTASES; MANAGEMENT; CAVITY; TRIAL; STAGE;
D O I
10.3390/cancers11020269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The most important prognostic factor in oral squamous cell carcinoma (OSCC) is neck metastasis, which is treated by neck dissection. Although selective neck dissection (SND) is a useful tool for clinically node-negative OSCC, its efficacy for neck node-positive OSCC has not been established. Sixty-eight OSCC patients with pN1-3 disease who were treated with curative surgery using SND and/or modified-radical/radical neck dissection (MRND/RND) were retrospectively reviewed. The neck control rate was 94% for pN1-3 patients who underwent SND. The five-year overall survival (OS) and disease-specific survival (DSS) in pN1-3 OSCC patients were 62% and 71%, respectively. The multivariate analysis of clinical and pathological variables identified the number of positive nodes as an independent predictor of SND outcome (OS, hazard ratio (HR) = 4.98, 95% confidence interval (CI): 1.48-16.72, p < 0.01; DSS, HR = 6.44, 95% CI: 1.76-23.50, p < 0.01). The results of this retrospective study showed that only SND for neck node-positive OSCC was appropriate for those with up to 2 lymph nodes that had a largest diameter 3 cm without extranodal extension (ENE) of the neck and adjuvant radiotherapy. However, the availability of postoperative therapeutic options for high-risk OSCC, including ENE and/or multiple positive lymph nodes, needs to be further investigated.
引用
收藏
页数:12
相关论文
共 43 条
[1]   Clinical Nodal Stage is a Significant Predictor of Outcome in Patients with Oral Cavity Squamous Cell Carcinoma and Pathologically Negative Neck Metastases: Results of the International Consortium for Outcome Research [J].
Amit, M. ;
Yen, T. C. ;
Liao, C. T. ;
Binenbaum, Y. ;
Chaturvedi, P. ;
Agarwal, J. P. ;
Kowalski, L. P. ;
Ebrahimi, A. ;
Clark, J. R. ;
Cernea, C. R. ;
Brandao, S. J. ;
Kreppel, M. ;
Zoeller, J. ;
Fliss, D. ;
Bachar, G. ;
Shpitzer, T. ;
Bolzoni, V. A. ;
Patel, P. R. ;
Jonnalagadda, S. ;
Robbins, K. T. ;
Shah, J. P. ;
Patel, S. G. ;
Gil, Ziv .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) :3575-3581
[2]  
[Anonymous], 2017, The AJCC TNM Cancer Staging Manual
[3]   Immunotherapy of Head and Neck Cancer: Emerging Clinical Trials From a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting [J].
Bauman, Julie E. ;
Cohen, Ezra ;
Ferris, Robert L. ;
Adelstein, David J. ;
Brizel, David M. ;
Ridge, John A. ;
O'Sullivan, Brian ;
Burtness, Barbara A. ;
Butterfield, Lisa H. ;
Carson, William E. ;
Disis, Mary L. ;
Fox, Bernard A. ;
Gajewski, Thomas F. ;
Gillison, Maura L. ;
Hodge, James W. ;
Quynh-Thu Le ;
Raben, David ;
Strome, Scott E. ;
Lynn, Jean ;
Malik, Shakun .
CANCER, 2017, 123 (07) :1259-1271
[4]  
Bierley JD., 2017, TNM classification of malignant tumors, V8th, DOI DOI 10.1002/EJOC.201200111
[5]  
Brandwein-Gensler A, 2005, AM J SURG PATHOL, V29, P167
[6]  
Brentani RR, 1998, AM J SURG, V176, P422
[7]   RATIONALE FOR ELECTIVE MODIFIED NECK DISSECTION [J].
BYERS, RM ;
WOLF, PF ;
BALLANTYNE, AJ .
HEAD & NECK SURGERY, 1988, 10 (03) :160-167
[8]   Functional assessment using constant's shoulder scale after modified radical and selective neck dissection [J].
Chepeha, DB ;
Taylor, RJ ;
Chepeha, JC ;
Teknos, TN ;
Bradford, CR ;
Sharma, PK ;
Terrell, JE ;
Wolf, GT .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (05) :432-436
[9]   Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck [J].
Cooper, Jay S. ;
Zhang, Qiang ;
Pajak, Thomas F. ;
Forastiere, Arlene A. ;
Jacobs, John ;
Saxman, Scott B. ;
Kish, Julie A. ;
Kim, Harold E. ;
Cmelak, Anthony J. ;
Rotman, Marvin ;
Lustig, Robert ;
Ensley, John F. ;
Thorstad, Wade ;
Schultz, Christopher J. ;
Yom, Sue S. ;
Ang, K. Kian .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05) :1198-1205
[10]   Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer [J].
D'Cruz, Anil K. ;
Vaish, Richa ;
Kapre, Neeti ;
Dandekar, Mitali ;
Gupta, Sudeep ;
Hawaldar, Rohini ;
Agarwal, Jai Prakash ;
Pantvaidya, Gouri ;
Chaukar, Devendra ;
Deshmukh, Anuja ;
Kane, Shubhada ;
Arya, Supreeta ;
Ghosh-Laskar, Sarbani ;
Chaturvedi, Pankaj ;
Pai, Prathamesh ;
Nair, Sudhir ;
Nair, Deepa ;
Badwe, Rajendra .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06) :521-529